711 related articles for article (PubMed ID: 17056237)
1. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
Serratoni M; Newton M; Booth S; Clarke A
Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
[TBL] [Abstract][Full Text] [Related]
2. The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization.
Newton JM; Pinto MR; Podczeck F
Eur J Pharm Sci; 2007 Mar; 30(3-4):333-42. PubMed ID: 17223021
[TBL] [Abstract][Full Text] [Related]
3. Self-emulsifying pellets: relations between kinetic parameters of drug release and emulsion reconstitution-influence of formulation variables.
Nikolakakis I; Malamataris S
J Pharm Sci; 2014 May; 103(5):1453-65. PubMed ID: 24596121
[TBL] [Abstract][Full Text] [Related]
4. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
[TBL] [Abstract][Full Text] [Related]
5. Approaches to developing fast release pellets via wet extrusion-spheronization.
Xia Y; Shi CY; Fang JG; Wang WQ
Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
Ibrahim MA
Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
[TBL] [Abstract][Full Text] [Related]
7. Multilayer laminar co-extrudate as a novel controlled release dosage form.
Müllers KC; Wahl MA; Pinto JF
Eur J Pharm Sci; 2013 Jul; 49(4):491-8. PubMed ID: 23747660
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of a self-emulsifying pellet formulation.
Abdalla A; Mäder K
Eur J Pharm Biopharm; 2007 May; 66(2):220-6. PubMed ID: 17196807
[TBL] [Abstract][Full Text] [Related]
9. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets.
Abdalla A; Klein S; Mäder K
Eur J Pharm Sci; 2008 Dec; 35(5):457-64. PubMed ID: 18940249
[TBL] [Abstract][Full Text] [Related]
10. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
Ishida M; Abe K; Hashizume M; Kawamura M
Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
[TBL] [Abstract][Full Text] [Related]
12. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
[TBL] [Abstract][Full Text] [Related]
13. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
[TBL] [Abstract][Full Text] [Related]
14. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
Yadav D; Survase S; Kumar N
Int J Pharm; 2011 Oct; 419(1-2):121-30. PubMed ID: 21807081
[TBL] [Abstract][Full Text] [Related]
15. [Studies on preparation of isosorbide-5-mononitrate pulsatile controlled-release pellets and various influence factors].
Wang R; Huang G; Fang Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):885-8. PubMed ID: 18788301
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of drug release from pellets coated with HPMC or Surelease.
Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2000 Jun; 26(6):651-60. PubMed ID: 10826113
[TBL] [Abstract][Full Text] [Related]
17. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
18. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
19. Preparation of lovastatin matrix sustained-release pellets by extrusion-spheronization combined with microcrystal dispersion technique.
He H; Shi B; Cai C; Tang X
Arch Pharm Res; 2011 Nov; 34(11):1931-8. PubMed ID: 22139692
[TBL] [Abstract][Full Text] [Related]
20. Self-Micro-Emulsifying Controlled Release of Eugenol Pellets: Preparation, In vitro/In vivo Investigation in Beagle Dogs.
Wang Q; Guo M; Adu-Frimpong M; Zhang K; Yang Q; Toreniyazov E; Ji H; Xu X; Cao X; Yu J
AAPS PharmSciTech; 2019 Aug; 20(7):284. PubMed ID: 31407165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
